Company Introduction

Flat Medical is a medtech company focusing on safety issues in clinical procedures. Its major product line, EpiFaith, is a safety solution for epidural, central line placement and many other blind puncture procedures, eliminating the potential adverse events lead by the risky procedure itself. Backed by medical KOLs and VCs across the globe, the company is commercializing it’s 1^st product, a FDA-cleared/ CE marked innovation, in the U.S., several EU countries and Japan with leading partners in the territories. 
醫盟科技致力於解決高風險之穿刺定位問題，並且以硬脊膜外腔注射為切入點，透過創新醫材研發，提供針頭定位之指引，藉以減少無痛分娩、慢性疼痛控制時定位失準，導致脊髓腔損傷的後遺症。第一項產品EpiFaith已於2019年4月通過美國FDA及歐盟CE認證，並在2019年6月開始供貨。後續將利用同一技術，解決其它盲刺定位問題，期能為醫師、病患帶來更安全且方便的使用情境。

Brief description of main products or services 

The 1^st product, EpiFaith, is a safety solution for epidural anesthesia. By transforming the subjective tactile feeling into the objective visual signal, EpiFaith has been recognized as a reliable product for a safer localization into the epidural space. The clinical benefit of EpiFaith can be translated into substantial cost-reduction for the healthcare organizations. By ceasing the accidental dural puncture, additional admission time, additional blood patch procedure and the risk of permanent paralysis, EpiFaith can help decrease the extra medical cost of $56-93 (USD) averagely for each patient. The product is now in its early launch status, being trialed and early adopted in several renowned hospitals in the U.S. and Europe.

The same tech is now being applied to another critical care procedure, central venous catheterization. The second product on the pipeline, EpiFaith CV, is a visual indicator that helps intensivists identify the arrival of vein/ artery in an easy and reliable manner. With the auto-aspiration and pressure sensing mechanism inside, EpiFaith CV is changing the blindly-accesses procedure into a fast and accurate one. EpiFaith CV is now under the final review and expected to be CE-marked (MDR) and FDA cleared in Q4, 2021.